medigraphic.com
ISSN 1659-1046 (Impreso)
Odovtos - International Journal of Dental Sciences

2016, Número 3

<< Anterior Siguiente >>

Odovtos-Int J Dent Sc 2016; 18 (3)


Trastorno de dolor dentoalveolar persistente: El paciente que nunca olvidará...

Cervantes-Chavarría AR, Montero-Aguilar M

Idioma: Español
Referencias bibliográficas: 45
Paginas: 17-25
Archivo PDF: 157.27 Kb.


RESUMEN

El Trastorno de Dolor Dentoalveolar Persistente (PDAP), es un dolor neuropático de origen no odontogénico, que puede resultar difícil de diagnosticar y generalmente se acompaña de una creciente ansiedad tanto de parte del paciente como también del odontólogo, debido a los múltiples infructuosos tratamientos en los que se suele incurrir para intentar solucionarlo. Una exhaustiva historia médica, acompañada de un examen clínico y radiográfico completo, así como las demás pruebas diagnósticas correspondientes según el caso, deben ayudar al odontólogo a obtener el diagnóstico lo más temprano posible para iniciar el tratamiento indicado para cada caso. El manejo interdisciplinario es recomendado, pues esta condición habitualmente abarca aspectos psicosociales del paciente, donde tiende a verse afectada su calidad de vida. Antes de iniciar un tratamiento clínico invasivo, el odontólogo responsable debe obtener un diagnóstico claro de la etiología del dolor y en caso de duda valorar la posibilidad de estar ante un caso de dolor no odontogénico, como el PDAP.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Abiko Y., Matsuoka H., Chiba I., Toyofuku A. Current evidence on atypical odontalgia: Diagnosis and clinical management. Int. J. Dent 2012; Article ID 518548. Doi:10.1155/2012/518548.

  2. Ito M., Kimura H., Yoshida K., Kimura Y., Ozaki N., Kurita K. Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region. Clin Neuropharmacol. 2010; 33 (2): 79-83.

  3. Markman S., Howard J., Quek S. Atypical odontalgia--a form of neuropathic pain that emulates dental pain. J NJ Dent Assoc. 2008; 79 (3): 27-31.

  4. List T., Leijon G., Helkimo M., Oster A., Dworkin S.F., Svensson P. Clinical findings and psychosocial factors in patients with atypical odontalgia: A case-control study. J Orofac Pain. 2007; 21 (2): 89-98.

  5. Moana-Filho E. J., Nixdorf D. R., Bereiter D. A., John M. T., Harel N. Evaluation of a magnetic resonance-compatible dentoalveolar tactile stimulus device. BMC Neurosci. 2010; 11: 142.

  6. Nixdorf D. R., Law A. S., John M. T., Sobieh R.M., Kohli R., Nguyen R.H., et al. Differential diagnoses for persistent pain after root canal treatment: A study in the national dental practice-based research network. J Endod. 2015; 41 (4): 457-63.

  7. Porporatti A. L., Costa Y. M., Stuginski- Barbosa J., Bonjardim L.R., Conti, P.C. Effect of topical anaesthesia in patients with persistent dentoalveolar pain disorders: A quantitative sensory testing evaluation. Arch Oral Biol. 2015; 60 (7), 973-81.

  8. Baad-Hansen L. Atypical odontalgia - pathophysiology and clinical management. J Oral Rehabil. 2008; 35 (1): 1-11.

  9. Forssell H., Jaaskelainen S., List T., Svensson P., Baad-Hansen, L. An update on pathophysiological mechanisms related to idiopathic orofacial pain conditions with implications for management. J Oral Rehabil. 2015 42 (4): 300-22.

  10. Nixdorf D. R., Moana-Filho E. J., Law A. S., McGuire L. A., Hodges J. S., John M.T. Frequency of nonodontogenic pain after endodontic therapy: A systematic review and meta-analysis. J. Endod. 2010; 36 (9): 1494-98.

  11. Porporatti A. L., Costa Y. M., Stuginski- Barbosa J., Bonjardim L. R., Conti P. C., Svensson P. Quantitative methods for somatosensory evaluation in atypical odontalgia. Braz. Oral Res. 2015; 29.

  12. Durham J., Nixdorf D. R. Healthcare pathway and biopsychosocial impact of persistent dentoalveolar pain disorder: A qualitative study. Int. Endod J. 2014; 47 (12): 1151-59.

  13. Takenoshita M., Sato T., Kato Y., Katagiri A., Yoshikawa T., Sato Y., et al. Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities. Neuropsychiatr Dis Treat. 2010;13 (6): 699-705.

  14. Baad-Hansen L., Leijon G., Svensson P., List, T. Comparison of clinical findings and psychosocial factors in patients with atypical odontalgia and temporomandibular disorders. J. Orofac Pain. 2008; 22 (1): 7-14.

  15. Vena D. A., Collie D., Wu H., Gibbs J. L., Broder H. L., Curro F.A., et al. Prevalence of persistent pain 3 to 5 years post primary root canal therapy and its impact on oral healthrelated quality of life: PEARL network findings. J. Endod. 2014; 40 (12): 1917-21.

  16. Marbach J., Hulbroc J. Incidence of Phantom Tooth Pain: an atypical facial neuralgia. Oral Surg Oral Med Oral Pathol. 1982; 53 (2): 190-3.

  17. Graff-Radford S. B., Solberg W. K. Atypical Odontalgia. J. Craniomand Disord. 1992; 6 (4): 260-5.

  18. Ciaramella A., Paroli M., Lonia L., Bosco M., Poli, P. Biopsychosocial aspects of atypical odontalgia. ISRN Neurosci. 2013; 5 doi:10.1155/2013/413515.

  19. Baad-Hansen L., List T., Jensen T.S., Leijon G., Svensson P. Blink reflexes in patients with atypical odontalgia. J. Orofac Pain. 2005; 19 (3): 239-47.

  20. Siqueira J.T., Lin H.C., Nasri C., Siqueira S.R., Teixeira M.J., Heir G., et al. Clinical study of patients with persistent orofacial pain. Arq Neuro-Psiquiat. 2004; 62 (4): 988-96.

  21. Berge T. I. Incidence of chronic neuropathic pain subsequent to surgical removal of impacted third molars. Acta Odontol Scand. 2002; 60 (2): 108-12.

  22. Baad-Hansen L., List T., Jensen T.S., Svensson P. Increased pain sensitivity to intraoral capsaicin in patients with atypical odontalgia. J. Orofac Pain. 2006; 20 (2): 107-114.

  23. Baad-Hansen L., List T., Kaube H., Jensen T. S., Svensson P. Blink reflexes in patients with atypical odontalgia and matched healthy controls. Exp Brain Res. 2006; 172 (4): 498-506.

  24. List T., Leijon G., Svensson P. Somatosensory abnormalities in atypical odontalgia: A casecontrol study. Pain. 2008; 139 (2): 333-341.

  25. Porporatti A. L., Costa Y. M., Stuginski- Barbosa J., Bonjardim L. R., Duarte M. A., Conti P. C. Diagnostic accuracy of quantitative sensory testing to discriminate inflammatory toothache and intraoral neuropathic pain. J. Endod. 2015; 41(10): 1606-13.

  26. Ram S., Teruel A., Kumar S. K., Clark, G. Clinical characteristics and diagnosis of atypical odontalgia: Implications for dentists. J. Am Dent Assoc. 2009; 140 (2): 223-28.

  27. Napenas J. J., Zakrzewska J. M. Diagnosis and management of trigeminal neuropathic pains. Pain Manag. 2011; 1 (4): 353-65.

  28. List T., Leijon G., Helkimo M., Oster A., Svensson P. Effect of local anesthesia on atypical odontalgia--a randomized controlled trial. Pain. 2006; 122 (3): 306-14.

  29. Pigg M. Chronic intraoral pain--assessment of diagnostic methods and prognosis. Swed Dent J. Suppl. 2011; (220): 7-91.

  30. Clark G.T. Persistent orodental pain, atypical odontalgia, and phantom tooth pain: When are they neuropathic disorders? J. Calif Dent Assoc. 2006; 34 (8): 599-609.

  31. Nixdorf D. R., Drangsholt M. T., Ettlin D. A., et al. Classifying orofacial pains: A new proposal of taxonomy based on ontology. J. Oral Rehabil 2012; 39 (3): 161-9.

  32. Klausner J. J. Epidemiology of chronic facial pain: diagnostic usefulness in patient care. J. Am Dent Assoc. 1994; 125 (12): 1604–11.

  33. Pigg M., Svensson P., Drangsholt M., List T. Seven-year follow-up of patients diagnosed with atypical odontalgia: A prospective study. J. Orofac Pain. 2013; 27 (2): 151-64.

  34. Melis M., Secci S. Diagnosis and treatment of atypical odontalgia: A review of the literature and two case reports. J. Contemp Dent Pract. 2007 1 (3): 81-9.

  35. Gallagher H. C., Gallagher R. M., Butler M., Buggy D. J., Henman M. C. Venlafaxine for neuropathic pain in adults. Cochrane Database Syst Rev. 2015; 8. doi:10.1002/14651858. CD011091.pub2.

  36. Nagashima W., Kimura H., Ito M., Tokura T., Arao M., Aleksic B., et al. Effectiveness of duloxetine for the treatment of chronic nonorganic orofacial pain. Clin Neuropharmacol. 2012; 35 (6): 273-7.

  37. Herrero B. A., Kapos F. P. Nixdorf D.R. Intraoral administration of botulinum toxin for trigeminal neuropathic pain. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 121 (6): 148-53.

  38. Cuadrado M. L., Garcia-Moreno H. Arias J. A., Pareja J. A. Botulinum Neurotoxin Type-A for the Treatment of Atypical Odontalgia. Pain Med. 2016; 17 (9): 1717-21.

  39. Oh H. M., Chung M. E. Botulinum toxin for neuropathic pain: A review of the literature. Toxins (Basel). 2015; 7 (8): 3127-54.

  40. Cho S. H., Whang W. W. Acupuncture for temporomandibular disorders: a systematic review. J. Orofac Pain. 2010; 24 (2): 152-162.

  41. Shueb S. S., Nixdorf D. R., John M. T., Alonso B. F., Durham J. What is the impact of acute and chronic orofacial pain on quality of life? J. Dent. 2015; 43 (10): 1203-10.

  42. Durham J., Exley C., John M. T., Nixdorf D. R. Persistent dentoalveolar pain: The patient's experience. J. Orofac Pain. 2013; 27 (1): 6-13.

  43. Khatchaturian V., de Wijer A., Kalaykova S. I., Steenks M. H. Toothache with a neuropathic background. Ned Tijdschr Tandheelkd. 2015; 122 (3): 142-4.

  44. Nixdorf D., Moana-Filho E. Persistent dentoalveolar pain disorder (PDAP): Working towards a better understanding. Rev Pain.2011; 5 (4): 18-27.

  45. Tarce M., Barbieri C., Sardella, A. Atypical odontalgia: An up-to-date view. Minerva Stomatol. 2013; 62 (5): 163-81.




2020     |     www.medigraphic.com